H1

Series-B+
h1.co Biotech & Healthcare New York City, United States 500 employees
Total Funding Undisclosed
Latest Round Undisclosed Series-B+
Last Announced Nov 12, 2021
Investors 1 Backer
Decision Makers 4 Verified

About H1

H1 is a series-b+-stage technology company operating in Biotech & Healthcare. The company is headquartered in New York City, United States. Notable investors include Y Combinator.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters New York City, United States
Team Size 500 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website h1.co
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

Investors & Backers

1
Y Combinator

Funding History

2 Rounds
Series-B+ · Nov 12, 2021
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

4

Ariel Katz

CEO & Co-founder

Work email & phone locked Unlock →

Ian Sax

Co-Founder

Work email & phone locked Unlock →

Nate Fox

Co-Founder, CTO & President

Work email & phone locked Unlock →

Nate Maslak

Co-Founder Ribbon, Chief Strategy Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts